Discussion - How to address residual risk post ACS: LDL-c, dyslipidemia, and inflammation.

29 August 2016 (13:40 - 13:45)
Organised by:
Congress Presentation Part of: How to address residual risk post ACS: LDL-c, dyslipidemia, and inflammation Inflammation and microcirculation ESC Premium Access ESC Congress 2016